Company Kane Biotech Inc Other OTC
Equities
CA4838091094
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
06-27 | Kane Biotech Completes First Commercial Sale of revyve Antimicrobial Wound Gel | MT |
06-27 | Kane Biotech Completes First Commercial Sale of revyve Antimicrobial Wound Gel to ProgenaCare Global | MT |
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
All Other
100.0
%
| 0 | 5.9 % | 0 | 100.0 % | -4.95% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
International
93.1
%
| 1 | 55.5 % | 0 | 93.1 % | -90.63% |
Canada
6.9
%
| 1 | 44.5 % | 0 | 6.9 % | -99.13% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Marc Edwards
CEO | Chief Executive Officer | - | 16-06-01 |
Ray Dupuis
DFI | Director of Finance/CFO | - | 17-09-04 |
Gregory Schultz
CTO | Chief Tech/Sci/R&D Officer | 73 | 22-04-04 |
John Coleman
BRD | Director/Board Member | - | 11-15 |
Corporate Officer/Principal | - | 19-08-11 | |
Wendy Nachtigall
SAM | Sales & Marketing | - | 15-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
R. Renaud
BRD | Director/Board Member | - | 10-09-14 |
Chairman | 59 | 02-19 | |
Georges Morin
BRD | Director/Board Member | - | 20-05-19 |
Marc Edwards
CEO | Chief Executive Officer | - | 16-06-01 |
John Coleman
BRD | Director/Board Member | - | 11-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 131,844,567 | 85,441,381 ( 64.80 %) | 0 | 64.80 % |
Company contact information
![address Kane Biotech Inc](https://cdn.zonebourse.com/static/address/104192.png)
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+19.41% | 45.51B | |
+38.65% | 39.36B | |
-8.62% | 38.52B | |
+26.95% | 30.74B | |
-13.50% | 26.03B | |
+10.74% | 25.92B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B |
- Stock Market
- Equities
- KNE Stock
- Stock
- Company Kane Biotech Inc